AKT1 and neoplasm: MiR-125b inhibits the PI3K/AKT pathway through downregulation of mRNA and protein PIK3CD via 3′-UTR binding, which is conducive to protein kinase A (AKT) and mTOR phosphorylation, inducing tumor growth volume inhibition [61] (Figure 1).